More changes are coming from the Food and Drug Administration as officials move to get rid of warning labels on some medications.Just last month, the administration announced it will remove black box ...
The revisions could make access much easier ...
The agency said it closed its warning letter against Whoop after the wearable company modified its Blood Pressure Insights ...
The FDA’s second major labeling update in 16 months — after its February 2025 removal of the cardiovascular boxed warning — marks a historic ...
Under a possible rule change outlined in a letter sent to supplement makers, the FDA would still require that warning on the package, but only once, rather than next to every health claim. HealthDay ...
The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...
FDA labeling now recommends DPYD variant testing before initiating capecitabine or 5-FU, except when immediate treatment is clinically necessary. Complete DPD deficiency markedly impairs 5-FU ...
The U.S. Food and Drug Administration (FDA) is weighing a change that could make warning labels on dietary supplements appear less often on packaging. Unlike prescription drugs, dietary supplements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results